LOS ANGELES, May 4 (Reuters) - Kathleen Jaeger, the chief lobbyist for the generic drugs industry during the debate over U.S. healthcare reform, is resigning as head of the Generic Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results